[Form 4] Life360, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Life360, Inc. (LIF) director James Synge reported multiple open-market dispositions of common stock equivalents tied to Australian CDIs between August 15 and August 18, 2025. The filings show sales of 24,919 and 81 common-stock-equivalent shares on August 15 at weighted average prices of $84.23 and $85.25 respectively, and a further 25,000 shares on August 18 at a weighted average price of $85.80, reflecting conversions from CDIs using a 1:3 ratio and AUD-to-USD exchange rates. After these transactions the reporting person directly held 194,754 common shares and indirectly held 3,966 shares through ICCA Labs, LLC, and the reported holdings include 2,810 unvested restricted stock units.

Positive

• Comprehensive disclosure of CDI conversions, FX rates, weighted-average prices, and indirect holdings provides transparency for investors
• Significant retained ownership after sales: 194,754 direct shares plus 3,966 indirect shares and 2,810 restricted stock units remain reported

Negative

• Material dispositions of approximately 49, ...000 common-share equivalents executed between August 15 and August 18, 2025, which reduce the reporting person's direct stake
• Multiple sale transactions at varying prices ($83.91 to $86.22 range) introduce variability in average proceeds and timing

Insights

Financial Analyst

TL;DR: Director sold roughly 50,000 common-share equivalents at ~$84–$86, but retains significant direct and indirect stake including RSUs.

The Form 4 discloses routine insider dispositions executed on the ASX via CDIs and converted to common-stock equivalents. The sales occurred across multiple transactions at weighted average prices of $84.23, $85.25, and $85.80, using specified conversion and FX rates. Post-sale ownership remains material at 194,754 direct shares plus 3,966 indirect and 2,810 restricted units, which limits the immediate governance impact. This is a compliance disclosure of executed sales rather than a strategic change in ownership.

Corporate Governance Expert

TL;DR: Disclosure follows Section 16 reporting rules; sales were processed through ASX CDIs and properly explained in footnotes.

The filing includes clear explanations about the CDI-to-common conversion (1:3), exchange rates used, weighted-average pricing ranges, and the reporting persons indirect holdings via an investment vehicle. The inclusion of restricted stock units and the disclaimer of beneficial ownership for certain indirect holdings are appropriate for transparency. There is no indication of a change in board status; filings indicate continued director relationship with the issuer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Synge James

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	08/15/2025		S(1)		24,919(2)	D	$84.23(3)(4)	219,835(5)(6)	D
Common stock	08/15/2025		S(1)		81(2)	D	$85.25(4)	219,754(5)(6)	D
Common stock	08/18/2025		S(1)		25,000(2)	D	$85.8(7)(8)	194,754(5)(6)	D
Common stock								3,966	I	Held by ICCA Labs, LLC(9)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale being reported on this Form 4 is the sale of Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs were traded on the Australian Securities Exchange (the "ASX") and were held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

2. Reflects the number of common stock equivalent shares underlying the CDIs sold on the ASX.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.91 to $84.85, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.

4. Reflects the weighted average sale price of the CDIs sold, as converted to USD by multiplying the amount by 3, based on the 3:1 conversion ratio for CDIs to common stock, and then multiplying by the exchange rate of 0.6505 in effect at the time of the sale as published by the Reserve Bank of Australia.

5. Includes the number of common stock underlying CDIs as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the ASX and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

6. Includes 2,810 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.36 to $86.22, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 7.

8. Reflects the weighted average sale price of the CDIs sold, as converted to USD by multiplying the amount by 3, based on the 3:1 conversion ratio for CDIs to common stock, and then multiplying by the exchange rate of 0.652 in effect at the time of the sale as published by the Reserve Bank of Australia.

9. The Reporting Person has shared investment control over Carthona Capital FS Pty Ltd. ("Carthona Capital"). Carthona Capital is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein represents Carthona Capital's proportionate ownership interest in ICCA Labs, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Remarks:

	/s/ Jay Sood, as Attorney-in-Fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Life360 (LIF) director James Synge sell?

Answer: Converted and sold common-stock-equivalent shares underlying ASX-traded CDIs: 24,919 and 81 shares on 08/15/2025 and 25,000 shares on 08/18/2025.

At what prices were the LIF shares sold?

Answer: Weighted average prices reported: $84.23 (08/15 sales), $85.25 (08/15 sale), and $85.80 (08/18 sale); underlying per-share ranges noted $83.91 to $86.22.

How many LIF shares does the reporting person own after these transactions?

Answer: The Form 4 reports 194,754 direct shares, 3,966 indirect shares held via ICCA Labs, LLC, and 2,810 restricted stock units included in the holdings.

Why were Australian CDIs mentioned in the filing?

Answer: The sales were of Chess Depositary Interests (CDIs) traded on the ASX; the filing explains a 1:3 CDI-to-common conversion and the AUD-to-USD exchange rates used to report USD prices.

Does the Form 4 indicate any change in the reporting persons role at Life360 (LIF)?

Answer: No. The filing identifies James Synge as a Director and does not report any change in relationship to the issuer.